期刊文献+

风湿性心脏病二尖瓣狭窄患者血浆肾素、血管紧张素和醛固酮变化与心房颤动的关系 被引量:1

下载PDF
导出
出处 《临床荟萃》 CAS 北大核心 2007年第3期200-201,共2页 Clinical Focus
基金 广西壮族自治区自然科学基金(No:0575069)
  • 引文网络
  • 相关文献

参考文献8

  • 1薛玉梅,刘震,吴书林.心房颤动住院患者1650例临床分析[J].中国实用内科杂志,2003,23(4):216-218. 被引量:37
  • 2Dilaveris P, Giannopoulos G,Synetos A, et al. The role of renin angiotensin system blockade in the treatment of atrial fibrillation[J]. Curt Drug Targets Cardiovasc Haematol Disord, 2005,5(5) :387-403.
  • 3伍伟锋,黄从新,刘唐威,李庚山.心房颤动患者心房组织血管紧张素Ⅱ受体表达的研究[J].中华心律失常学杂志,2002,6(4):211-214. 被引量:23
  • 4周胜华,沈向前,祁述善,林振武.经皮二尖瓣球囊成形术前后RAAS的变化[J].湖南医科大学学报,1994,19(5):433-435. 被引量:4
  • 5Ausma J,Wijffels M, Thone F,et al. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat[J]. Circulation, 1997,96(9): 3157-3163.
  • 6Wachtell K, Lehto M, Gerdts E,et al. Angiotensin Ⅱ receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol, the Losartan Intervention For End Point Reduction in Hypertension(LIFE) study[J], J Am Coll Cardiol, 2005,45(5):712-719.
  • 7Vermes E, Tardif JC, Bourassa MG, et al. Enalapril decreases the incidence of atrial fibrillation in patients with left ventrieular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) Trials [J]. Circulation, 2003,107 (23):2926-2931.
  • 8Madrid AH ,Bueno MG,Rehollo JMG,et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study [J].Circulation, 2002,106(3) : 331-336.

二级参考文献15

  • 1[1]Kannel WB, Abbott RD, Savage DD, et al. Epidemiologic features of chronic atrial fibrillation: the Framingham study[J]. N Engl J Med, 1982, 306:1018~1022
  • 2[2]Stewart S, Maclntyre K, Macleod MMC, et al. Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986-1996[J]. Eur Heart J, 2001, 22(8): 693~701
  • 3[3]Levy S, Maarek M, Coumel P, et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. Circulation, 1999, 99: 3028-3035
  • 4[4]Igarashi Y, Kasai H, Yamashita F, et al. Lipoprotein(a), left atrial appendage function and thromboembolic risk in patients chronic non-valvular atrial fibrillation[J]. Jpn Circ J, 2000, 64: 93~98
  • 5[5]Petersen P. Thromboembolic complications in atrial fibrillation[J]. Stroke, 1990, 21: 4~13
  • 6[6]Wolf PA, Abbott RD, Kannel WB, et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham study[J]. Stroke, 1991, 22: 983~988
  • 7[7]Hart RG,Benavent O,MeBride R,et al.Antithrombotic therapy to prevent stroke in patients with atrial fibrillation:a meta-analysis[J].Ann Intern Med,1999,131:492~501
  • 8[8]Gage BF, Boechler M, Doggette AL, et al. Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation[J]. Stroke, 2000, 31: 822~827
  • 9Van den Berg MP,Crijns HJGM, Van veldhuisen DJ,et al.Effects of lisinopril in patient with heart failure and chronic atrial fibrillation. J Card Failure, 1995,1: 355-363.
  • 10Pedersen OD,Bagger H,Kober L,et al. Trandolapril reduces the incidence of atrial fibrillation after acure myocardial infarction in patients with left ventricular dysfunction. Circulation, 1999,100: 376-380.

共引文献60

同被引文献15

  • 1肖锡俊,袁宏声,唐红,黄云,邵换璋,钱永军.二尖瓣置换时采用盐水冲洗的射频改良迷宫手术治疗心房颤动[J].中华心律失常学杂志,2006,10(5):342-344. 被引量:13
  • 2Roshanali F, Mandegar MH, Yousefnia MA, et al. Prevention of atrial fibrillation after coronary artery bypass grafting via atrial elec-tromechanical interval and use of amiodarone prophylaxis [J]. hl- teract Cardiovasc Thorac Surg, 2009, 8(4) : 421 -425.
  • 3Climent V, Marin F, Mainar L, et al. Influence of electrical card- ioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation [ J ]. Int J Cardiol, 2009, 132 (2) : 227 - 232.
  • 4Passier RC, Smits JF, Vcrluyten MJ, et al. Expression amt locali- zation of renin and angiotensinogcn in rat heart after myocardial in- farction [J]. Am J Physiol, 1996, 271 (3 Pt 2): I:11040- H1048.
  • 5Redpath CJ, Rankin AC, Kane KA, et al. Anti - adrenergic effects of endothelin on human atrial action potentials arc poten- tially anti - arrhythnfic [J]. J Mol Cell Cardiol, 2006,40 ( 5 ) : 717 -724.
  • 6BrundeX BJ, Van Gelder IC, Tuinenburg AE, et al. Endothelin system in human persistent and paroxysmal atrial fibrillation [ J ]. J Cardiovasc Electrophysiol, 2001,12 (7) :737 - 742.
  • 7Kiss O, Zima E, So6s P, et al. Intraconary endothelin - 1 infu- sion combined with systemic isoproterenol treatment: antagonistic arrhythmogenic effect [J]. Life Sci, 2004,75 (5) :537 - 548.
  • 8Burstein B, Nattel S. Atrial fibrosis: mechanisms and c]inical relevance in atrial fibrillation [J]. J Am Coil Cardiol, 2008, 51 (8) : 802 - 809.
  • 9Choi JO, Han H, Cho SJ, et al. Reduced peak atrial systolic mi- tral annular velocity predicts the development of nonvalvular atrial fibrillation [ J ]. Echocardiography, 2009,26 (6) :645 - 650.
  • 10Birnie DH, Gollob M, Healey JS, et al. Clinical "trials, the renin angiotensin system and atrial fibrillation [ J]. Curr Opin Cardiol, 2006,21 (4) :368 -375.

引证文献1

二级引证文献1

;
使用帮助 返回顶部